DDInter1471 DDInter1180
Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension. Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia. Research into pindolol's use in the treatment of hypertension began in the early 1970s. Pindolol was granted FDA approval on 3 September 1982.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Pindolol {u} (Compound) resembles {v} (Compound) Betaxolol
Pindolol {u} (Compound) resembles {v} (Compound) Atenolol
Pindolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Pindolol {u} (Compound) treats {v} (Disease) hypertension
Pindolol {u} (Compound) binds {v} (Gene) HTR1A
Pindolol {u} (Compound) upregulates {v} (Gene) TBP
Pindolol {u} (Compound) downregulates {v} (Gene) PTK2B
Pindolol {u} (Compound) causes {v} (Side Effect) Dyspepsia
Pindolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Sucralfate
Pindolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magaldrate
Pindolol (Compound) resembles Betaxolol (Compound)
Pindolol (Compound) resembles Atenolol (Compound)
Pindolol may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline
Pindolol (Compound) treats hypertension (Disease)
Pindolol (Compound) binds HTR1A (Gene)
Pindolol (Compound) upregulates TBP (Gene)
Pindolol (Compound) downregulates PTK2B (Gene)
Pindolol (Compound) causes Dyspepsia (Side Effect)
Pindolol may cause a minor interaction that can limit clinical effects when taken with Sucralfate
Pindolol may cause a minor interaction that can limit clinical effects when taken with Magaldrate